TY - JOUR
KW - Asthma
KW - inhaler devices
AU - A. Wilkinson
AU - E. Maslova
AU - C. Janson
AU - V. Radhakrishnan
AU - J. Quint
AU - N. Budgen
AU - T. Tran
AU - Y. Xu
AU - A. Menzies-Gow
AU - J. Bell
AD - Department of Respiratory Medicine, East and North Hertfordshire NHS Trust, Stevenage, UK.
BioPharmaceuticals Medical, AstraZeneca UK Ltd, Cambridge, UK.
Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
ZS Associates, Bengaluru, India.
National Heart Lung Institute, Imperial College London, London, UK.
Global Sustainability, AstraZeneca, Macclesfield, UK.
BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.
BioPharmaceuticals Medical, AstraZeneca Switzerland, Baar, Switzerland john.bell2@astrazeneca.com.
AN - 38413192
BT - Thorax
DO - 10.1136/thorax-2023-220259
DP - NLM
ET - 2024/02/28
LA - eng
N1 - 1468-3296
Wilkinson, Alexander J K
Orcid: 0000-0002-1808-3663
Maslova, Ekaterina
Janson, Christer
Orcid: 0000-0001-5093-6980
Radhakrishnan, Vasanth
Quint, Jennifer K
Orcid: 0000-0003-0149-4869
Budgen, Nigel
Tran, Trung N
Xu, Yang
Menzies-Gow, Andrew
Bell, John P
Orcid: 0000-0001-9307-1235
Journal Article
England
Thorax. 2024 Feb 27:thorax-2023-220259. doi: 10.1136/thorax-2023-220259.
PY - 2024
SN - 0040-6376
T2 - Thorax
TI - Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study
ER -